Author

Jeffrey S. Baggish

Observed names: J S Baggish, J. Baggish, J.S. Baggish, Jeffrey Baggish, Jeffrey S Baggish

Observed institutions: University of North Carolina at Chapel Hill, CSL (United States)

OpenAlex ID: A5023210658

Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials

2005 · Victor L. Serebruany, Steven R. Steinhubl, et al. · The American Journal of Cardiology · 343

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy

2012 · J S Orange, B H Belohradsky, et al. · Clinical & Experimental Immunology · 139

Efficacy and Safety of Acetaminophen in the Treatment of Migraine

2000 · Richard B. Lipton, Jeffrey S. Baggish, et al. · Archives of Internal Medicine · 139

Coping strategies and health care—seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder

2001 · Judith A. Ricci, Jeffrey S. Baggish, et al. · Clinical Therapeutics · 128

IBS Patients Show Frequent Fluctuations Between Loose/Watery and Hard/Lumpy Stools: Implications for Treatment

2011 · Olafur S Palsson, Jeffrey S Baggish, et al. · The American Journal of Gastroenterology · 98

Aspirin Is Efficacious for the Treatment of Acute Migraine

2005 · Richard B. Lipton, Jerome Goldstein, et al. · Headache The Journal of Head and Face Pain · 89

PDF

Acetaminophen, Aspirin, and Caffeine Versus Sumatriptan Succinate in the Early Treatment of Migraine: Results From the ASSET trial

2005 · Jerome Goldstein, Stephen D. Silberstein, et al. · Headache The Journal of Head and Face Pain · 85

Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials

2006 · Edwin K. Kuffner, Anthony R. Temple, et al. · Current Medical Research and Opinion · 62

Episodic Nature of Symptoms in Irritable Bowel Syndrome

2014 · Olafur S Palsson, Jeffrey Baggish, et al. · The American Journal of Gastroenterology · 45

Higher Doses of Subcutaneous IgG Reduce Resource Utilization in Patients with Primary Immunodeficiency

2011 · Elie Haddad, Melvin Berger, et al. · Journal of Clinical Immunology · 28

PDF

Safety of L -proline as a stabilizer for immunoglobulin products

2012 · John B Hagan, Richard L Wasserman, et al. · Expert Review of Clinical Immunology · 17

Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety

2011 · Christopher A. Jones, Mikhail Rojavin, et al. · Journal of Pharmaceutical Health Services Research · 14

Increased Frequency of Infections at the End of the IVIG Dosing Cycle: Effect Characterization from Three Phase III Studies

2012 · M. Bexon, J.S. Baggish, et al. · Journal of Allergy and Clinical Immunology · 4

Evaluation of the Relationship between Injection Site Reaction Rate and SCIG Doses in Patients with Primary Immunodeficiencies

2012 · O. Zenker, M. Rojavin, et al. · Journal of Allergy and Clinical Immunology · 1

Recommendations for Probiotic Use-2008 Cited Data Do Not Support “A” Recommendation for Infectious Diarrhea in Adults

2009 · Jeffrey S. Baggish · Journal of Clinical Gastroenterology · 1

M1223 Characterizing Diarrhea in Irritable Bowel Syndrome (IBS)

2009 · Olafur S. Palsson, Marsha J. Turner, et al. · Gastroenterology · 1

Tu2070 Symptom Episode Patterns in Irritable Bowel Syndrome (IBS)

2013 · Olafur S. Palsson, Jeffrey S. Baggish, et al. · Gastroenterology

Low-Level Alanine Aminotransferase Elevations in Osteoarthritis Patients within Approximately 2 Weeks of Treatment Initiation with Daily Acetaminophen: A Retrospective Analysis Evaluating Subsequent Alanine Aminotransferase Activity on Continued Acetaminophen Therapy

2013 · Edwin K. Kuffner, Kimberly M. Cooper, et al. · Clinical Medicine Insights Therapeutics

Subcutaneous immunoglobulin therapy for patients with PID provides economic value across a wide range of dosing

2012 · Art Zbrozek, Alphonse Hubsch, et al. · F1000Research

Increased frequency of infections at the end of the IVIG dosing cycle: effect characterization from three Phase III studies

2012 · Martin Bexon, Jeffrey S. Baggish, et al. · F1000Research

Tu1387 The Significance of Days With No Stools in Irritable Bowel Syndrome (IBS)

2012 · Olafur S. Palsson, Marsha J. Turner, et al. · Gastroenterology

Incidence of Respiratory Tract Infections in Clinical Trials of Intravenous and Subcutaneous Immunoglobulin

2012 · J.S. Baggish, M. Bexon, et al. · Journal of Allergy and Clinical Immunology

PDF

A systematic review of patient-reported outcomes in neurological disorders and primary immunodeficiencies with an emphasis on patient confidence in relation to immunoglobulin therapy: The last five years

2011 · Christopher A. Jones, Jeffrey S. Baggish · F1000Research

How Good Are Individuals at Predicting Diarrhea Based on Perceived Triggers and Warning Sensations?: A Diary Study

2011 · Olafur S. Palsson, Marsha J. Turner, et al. · Gastroenterology

U.S. Clinical Experience with Privigen®: A Retrospective Chart Review

2011 · D. Wong, R. Hellmers, et al. · Journal of Allergy and Clinical Immunology

Works count: 30

Citation count: 1,194

H-index: 12

I10-index: 12